Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy.

Full Abstract

Bone marrow-derived mononuclear cells (BMNCs) have been shown to effectively treat ischemic cardiovascular diseases. Because diabetic neuropathy (DN) is causally associated with impaired angiogenesis and deficiency of angiogenic and neurotrophic factors in the nerves, we investigated whether DN can be ameliorated by local injection of BMNCs. Severe peripheral neuropathy, characterized by a significant decrease in the motor and sensory nerve conduction velocities (NCVs), developed 12 weeks after the induction of diabetes with streptozotocin in rats. The injection of BMNCs restored motor and sensory NCVs to normal levels and significantly improved vascular density and blood flow in diabetic nerves over 4 weeks. Fluorescent microscopic observation revealed that DiI-labeled BMNCs preferentially engrafted in sciatic nerves. Whole-mount fluorescent imaging and confocal microscopic evaluation demonstrated that many of the BMNCs localized following the course of the vasa nervorum in close proximity to blood vessels without incorporation into vasa nervorum as endothelial cells at a detectable level. Real-time reverse transcription-polymerase chain reaction analysis showed that the levels of angiogenic and neurotrophic factors were significantly increased in the nerves by BMNC injection. Local transplantation of BMNCs improved experimental DN by augmenting angiogenesis and increasing angiogenic and neurotrophic factors in peripheral nerves. These findings suggest that BMNC transplantation may represent a novel therapeutic option for treating DN.

Author information

Author/s: Kim, Hyongbum (H); Park, Jong-seon (JS); Choi, Yong Jin (YJ); Kim, Mee-Ohk (MO); Huh, Yang Hoon (YH); Kim, Sung-Whan (SW); Han, Ji Woong (JW); Lee, JiYoon (J); Kim, Sinae (S); Houge, Mackenzie A (MA); Ii, Masaaki (M); Yoon, Young-sup (YS);

Affiliation: Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Grants: HL079137 (Agency:NHLBI NIH HHS) ; HL084471 (Agency:NHLBI NIH HHS) ; R01 HL079137-01 (Agency:NHLBI NIH HHS) ; R01 HL079137-02 (Agency:NHLBI NIH HHS) ; R01 HL079137-03 (Agency:NHLBI NIH HHS) ; R01 HL079137-04 (Agency:NHLBI NIH HHS) ; R01 HL079137-05 (Agency:NHLBI NIH HHS) ; R01 HL079137-05S1 (Agency:NHLBI NIH HHS) ; R01 HL079137-06 (Agency:NHLBI NIH HHS) ; R01 HL084471-01 (Agency:NHLBI NIH HHS) ; R01 HL084471-02 (Agency:NHLBI NIH HHS) ; R01 HL084471-03 (Agency:NHLBI NIH HHS) ; R01 HL084471-04 (Agency:NHLBI NIH HHS) ; R01 HL084471-05 (Agency:NHLBI NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal: Stem cells (Dayton, Ohio) (Stem Cells), published in United States. (Language: eng)

Reference: 2009-Jul; vol 27 (issue 7) : pp 1686-96

Dates: Created 2009/08/03; Completed 2009/10/30;

PMID: 19544451, status: MEDLINE (last retrieval date: 10/30/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.